Loading…
BioRestorative Therapies, Inc. is projected to rise to $0.3927 by 2027, a +14% move from its current price of $0.345. BRTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.3258 | $0.3448 | $0.3648 | -0.06% |
| Jul 15 | $0.3181 | $0.3446 | $0.3732 | -0.13% |
| Jul 16 | $0.3123 | $0.3443 | $0.3797 | -0.19% |
| Jul 17 | $0.3074 | $0.3441 | $0.3853 | -0.25% |
| Jul 18 | $0.3031 | $0.3439 | $0.3902 | -0.32% |
| Jul 19 | $0.2993 | $0.3437 | $0.3947 | -0.38% |
| Jul 20 | $0.2958 | $0.3435 | $0.3988 | -0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2958 | $0.3435 | $0.3988 | -0.44% |
| Week 2 | $0.2768 | $0.342 | $0.4224 | -0.88% |
| Week 3 | $0.2628 | $0.3404 | $0.441 | -1.32% |
| Week 4 | $0.2514 | $0.3389 | $0.457 | -1.76% |
| Week 5 | $0.2416 | $0.3374 | $0.4713 | -2.19% |
| Week 6 | $0.233 | $0.336 | $0.4845 | -2.62% |
| Week 7 | $0.2252 | $0.3345 | $0.4967 | -3.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioRestorative Therapies, Inc. is a healthcare company that develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. Its programs target disc/spine disease and metabolic disorders, with a pipeline that includes BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow, for non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue.
The company also operates a commercial biocosmeceutical platform and provides an investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body.
BioRestorative Therapies, Inc. (BRTX) is a healthcare company. The current price is $0.3454 and the market cap is $8.8M. The company is ranked 5147 in market capitalization.
The forecast shows a rising price path over the medium-to-long term, with a 2026 average price of $0.3454 and a 2050 average of $2.49, plus a 2050 high of $5.73 and a maximum ROI of 620.7%. The sentiment turns from Neutral around 2026-2027 to Bullish from 2028 onward, indicating potential upside over time.
These are estimates and not guarantees; actual results may vary based on market and company developments.
A major floor 50.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 38.8% above — a clean break opens room to run.
A major ceiling 52.9% above — clearing it would confirm fresh momentum.
Key BRTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BRTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3606 | Sell | $0.3566 | Sell |
| MA 10 | $0.3704 | Sell | $0.3666 | Sell |
| MA 20 | $0.3785 | Sell | $0.368 | Sell |
| MA 50 | $0.3201 | Buy | $0.3524 | Sell |
| MA 100 | $0.2873 | Buy | $0.4345 | Sell |
| MA 200 | $0.7686 | Sell | $0.6918 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.18 | Neutral |
| Stoch RSI (14) | 0.88 | Buy |
| CCI (20) | -123.69 | Sell |
| Williams %R (14) | -99.22 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -10.02 | Sell |
| Bollinger %B (20,2) | 0.10 | Neutral |
| Stochastic %K (14) | 0.78 | Buy |
| TRIX (15) | 0.68 | Buy |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 31.42 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 0.34 | Buy |
| ADX (14) | 12.97 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 50, signaling balanced momentum around the midpoint.
The 50-day simple moving average is $0.3154 and the 200-day simple moving average is $0.7798, indicating a closer-to-term price action near the $0.32 area with longer-term resistance higher up. Support is at $0.2498 and resistance at $0.479.
The 30-day price range spans $0.2324 to $0.5133, providing a near-term band within which the stock has traded recently.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.1698 | $0.345 | $0.4674 | 0% | Neutral | |
| $0.2849 | $0.3927 | $0.5852 | +14% | Neutral | |
| $0.3489 | $0.511 | $0.8115 | +48% | Bullish | |
| $0.4175 | $0.6442 | $1.07 | +87% | Bullish | |
| $0.3958 | $0.6402 | $1.11 | +86% | Bullish | |
| $0.3968 | $0.6708 | $1.21 | +94% | Bullish | |
| $0.3635 | $0.641 | $1.19 | +86% | Bullish | |
| $0.291 | $0.5343 | $1.02 | +55% | Bullish | |
| $0.4207 | $0.8037 | $1.57 | +133% | Bullish | |
| $0.5292 | $1.05 | $2.10 | +205% | Bullish | |
| $0.509 | $1.13 | $2.48 | +228% | Bullish | |
| $1.23 | $2.73 | $6.28 | +692% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.1698 | $0.345 | $0.4375 | +0.00% |
| August 2026 | $0.291 | $0.3524 | $0.4445 | +2.15% |
| September 2026 | $0.2651 | $0.3257 | $0.4194 | -7.59% |
| October 2026 | $0.2688 | $0.3343 | $0.438 | +2.64% |
| November 2026 | $0.2857 | $0.359 | $0.4773 | +7.41% |
| December 2026 | $0.2735 | $0.347 | $0.4674 | -3.36% |
Click any year to see its month-by-month BRTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BRTX is projected to trade between $0.1698 and $0.4674, averaging $0.345 — a potential gain of 0% from today's $0.345. A consolidation phase looks the most probable path here.
BioRestorative Therapies, Inc.'s 2027 outlook centres on $0.3927, within a $0.2849 to $0.5852 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2028, BRTX could reach as high as $0.8115, with a base case around $0.511 and support toward $0.3489 — roughly +48% from $0.345. Buyers look set to stay in control over this stretch.
Expect BRTX to range from $0.4175 to $1.07 through 2029. The $0.6442 average target implies a +87% move from current prices. That is up +26% on the projected 2028 average. Momentum favours further upside here.
The BRTX price prediction for 2030 points to an average of $0.6402 (low $0.3958, high $1.11) — a potential gain of +86% on today's $0.345. Buyers look set to stay in control over this stretch.
In 2031, BRTX is projected to trade between $0.3968 and $1.21, averaging $0.6708 — a potential gain of +94% from today's $0.345. That is up +5% on the projected 2030 average. Momentum favours further upside here.
BioRestorative Therapies, Inc.'s 2032 outlook centres on $0.641, within a $0.3635 to $1.19 range. That is -4% versus the projected 2031 average. That marks a +86% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BRTX could reach as high as $1.02, with a base case around $0.5343 and support toward $0.291 — roughly +55% from $0.345. Momentum favours further upside here.
Expect BRTX to range from $0.4207 to $1.57 through 2034. The $0.8037 average target implies a +133% move from current prices. That is up +50% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The BRTX price prediction for 2035 points to an average of $1.05 (low $0.5292, high $2.10) — a potential gain of +205% on today's $0.345. Momentum favours further upside here.
In 2040, BRTX is projected to trade between $0.509 and $2.48, averaging $1.13 — a potential gain of +228% from today's $0.345. That is up +8% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BioRestorative Therapies, Inc.'s 2050 outlook centres on $2.73, within a $1.23 to $6.28 range. That is up +142% on the projected 2040 average. That marks a +692% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BRTX today (≈ 2,898.550725 BRTX) could be worth
$7,919.85
+$6,919.85 (+692%) by 2050 · US Dollar
Based on the average projected BRTX price of $2.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BRTXwould be worth at today's price.
$1,000 invested in BRTX on Jul 10, 2025 (≈ 624.999991 BRTX) would be worth
$215.62
-$784.38 (-78.4%) today · 0.22× · US Dollar
Based on a BRTX entry price of $1.6 vs. today's $0.345.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.4 | $862.5 | -13.8% |
| 1 month ago | $0.38 | $907.89 | -9.2% |
| 3 months ago | $0.2406 | $1,433.92 | +43.4% |
| 6 months ago | $1.18 | $291.8 | -70.8% |
| 1 year ago | $1.6 | $215.62 | -78.4% |
| All time (5.0y) ago | $20.4 | $16.91 | -98.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BRTX forecast.
Our base-case forecast reaches $0.69 around 2034.
Implied market cap at $0.69: $17.58M
The multi-year forecast shows a bullish trajectory beginning in 2028, with the average price rising from $0.4931 in 2028 to $2.49 by 2050 and the max increasing to $5.73 in 2050.
Key yearly milestones include 2029 average $0.6197 and 2030 average $0.6223, with 2031 at $0.6438 and corresponding ROIs of 79.4%, 80.2%, and 86.4%, respectively.
From 2032 through 2035, the model yields averages of $0.6064, $0.5102, $0.751, and $0.9738 with ROIs of 75.6%, 47.7%, 117.4%, and 181.9%. By 2040, the average is $1.04 with an ROI of 201.8%, and by 2050 the average reaches $2.49 with an ROI of 620.7% and a max of $5.73. The sentiment for these later years is BULLISH.
These projections illustrate meaningful upside potential but remain estimates, not guarantees, and depend on future market and company developments.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $0.6223, with a min of $0.3846, a max of $1.08, and a projected ROI of 80.2% with a BULLISH sentiment.
The outlook moves from Neutral in 2026-2027 to Bullish from 2028 onward, with the 2028 average at $0.4931 and the 2050 average at $2.49, plus a 2050 max of $5.73 and a 620.7% ROI. These are estimates and not guarantees.
Yes. The forecast lists a 2050 max of $5.73 with a 2050 average of $2.49 and a 620.7% ROI.
Current price is $0.3454 and market cap is $8.8M.
The sentiment is NEUTRAL with RSI(14) at 50. The SMA50 is $0.3154 and the SMA200 is $0.7798. Support is $0.2498 and resistance is $0.479. The 30-day range runs from $0.2324 to $0.5133.
BioRestorative Therapies, Inc. Community Discussion
0Share your BioRestorative Therapies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.